PROFILE - IPF | Toby Maher, MD 

Toby Maher, MD of Imperial College London discusses the history of the PROFILE study and the goal to use genomics, epigenomics transcriptomics, metabolomics, proteomics, and the microbiome along with the detailed clinical phenotype information of patients to better understand IPF.
Social media platforms -
Twitter - @PFFORG
Facebook - @PFFORG
Instagram - @PFFORG
LinkedIn- Pulmonary Fibrosis Foundation
Please note that any information contained in this presentation is for informational and/or educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition.
This presentation is protected by U.S. and International copyright laws. Reproductions and distribution of this presentation without written permission from the Pulmonary Fibrosis Foundation is prohibited.
© 2020 Pulmonary Fibrosis Foundation